BIOMAT Database Logo BIOMAT Database Logo

Contact dermatitis due to the beta-blocker befunolol [corrected] in eyedrops. 1988

T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Department of Dermatology, Nagoya City University Medical School, Japan.

UI MeSH Term Description Entries
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D005901 Glaucoma An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) Glaucomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D013999 Timolol A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. (S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol,2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-,Blocadren,L-714,465,MK-950,Optimol,Timacar,Timolol Hemihydrate,Timolol Maleate,Timolol Maleate, (1:1) Salt,Timoptic,Timoptol,L 714,465,L714,465,MK 950,MK950

Related Publications

T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Allergic contact dermatitis due to the beta-blocker befunolol in eyedrops, with cross-sensitivity to carteolol.
June 2001, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
[Contact dermatitis due to befunolol hydrochloride eyedrops].
September 1987, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Allergic contact dermatitis due to befunolol in eyedrops.
September 1992, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Allergic contact dermatitis due to the beta-blocker carteolol in eyedrops.
November 1999, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Allergic contact dermatitis due to the beta-blocker betaxolol in eyedrops, with cross-sensitivity to timolol.
May 2010, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Contact dermatitis due to levobunolol in eyedrops.
April 1997, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Allergic contact dermatitis due to dorzolamide eyedrops.
January 2021, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Allergic contact dermatitis due to dorzolamide eyedrops.
July 2001, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Contact dermatitis due to chlorpheniramine maleate in eyedrops.
January 1990, Contact dermatitis,
T Kanzaki, and N Kato, and Y Kabasawa, and N Mizuno, and M Yuguchi, and A Majima
Allergic contact dermatitis due to levobunolol with cross-sensitivity to befunolol.
January 2007, Contact dermatitis,
Copied contents to your clipboard!